3-4362153-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182760.4(SUMF1):​c.1116T>C​(p.Thr372Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.587 in 1,613,514 control chromosomes in the GnomAD database, including 284,898 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.67 ( 35126 hom., cov: 34)
Exomes 𝑓: 0.58 ( 249772 hom. )

Consequence

SUMF1
NM_182760.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.0940

Publications

29 publications found
Variant links:
Genes affected
SUMF1 (HGNC:20376): (sulfatase modifying factor 1) This gene encodes an enzyme that catalyzes the hydrolysis of sulfate esters by oxidizing a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also known as C-alpha-formylglycine. Mutations in this gene cause multiple sulfatase deficiency, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
SUMF1 Gene-Disease associations (from GenCC):
  • mucosulfatidosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 3-4362153-A-G is Benign according to our data. Variant chr3-4362153-A-G is described in ClinVar as Benign. ClinVar VariationId is 96559.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.85 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SUMF1NM_182760.4 linkc.1116T>C p.Thr372Thr synonymous_variant Exon 9 of 9 ENST00000272902.10 NP_877437.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SUMF1ENST00000272902.10 linkc.1116T>C p.Thr372Thr synonymous_variant Exon 9 of 9 1 NM_182760.4 ENSP00000272902.5

Frequencies

GnomAD3 genomes
AF:
0.665
AC:
101084
AN:
152050
Hom.:
35060
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.858
Gnomad AMI
AF:
0.602
Gnomad AMR
AF:
0.691
Gnomad ASJ
AF:
0.625
Gnomad EAS
AF:
0.757
Gnomad SAS
AF:
0.753
Gnomad FIN
AF:
0.584
Gnomad MID
AF:
0.642
Gnomad NFE
AF:
0.544
Gnomad OTH
AF:
0.664
GnomAD2 exomes
AF:
0.643
AC:
160356
AN:
249294
AF XY:
0.638
show subpopulations
Gnomad AFR exome
AF:
0.869
Gnomad AMR exome
AF:
0.744
Gnomad ASJ exome
AF:
0.608
Gnomad EAS exome
AF:
0.765
Gnomad FIN exome
AF:
0.577
Gnomad NFE exome
AF:
0.552
Gnomad OTH exome
AF:
0.611
GnomAD4 exome
AF:
0.578
AC:
845195
AN:
1461346
Hom.:
249772
Cov.:
46
AF XY:
0.582
AC XY:
422914
AN XY:
726978
show subpopulations
African (AFR)
AF:
0.874
AC:
29274
AN:
33476
American (AMR)
AF:
0.731
AC:
32698
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.602
AC:
15723
AN:
26132
East Asian (EAS)
AF:
0.773
AC:
30684
AN:
39690
South Asian (SAS)
AF:
0.735
AC:
63424
AN:
86244
European-Finnish (FIN)
AF:
0.574
AC:
30643
AN:
53378
Middle Eastern (MID)
AF:
0.637
AC:
3645
AN:
5720
European-Non Finnish (NFE)
AF:
0.542
AC:
602644
AN:
1111606
Other (OTH)
AF:
0.604
AC:
36460
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
17853
35707
53560
71414
89267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17326
34652
51978
69304
86630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.665
AC:
101212
AN:
152168
Hom.:
35126
Cov.:
34
AF XY:
0.670
AC XY:
49827
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.858
AC:
35652
AN:
41556
American (AMR)
AF:
0.691
AC:
10573
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.625
AC:
2169
AN:
3468
East Asian (EAS)
AF:
0.758
AC:
3911
AN:
5160
South Asian (SAS)
AF:
0.753
AC:
3631
AN:
4824
European-Finnish (FIN)
AF:
0.584
AC:
6176
AN:
10578
Middle Eastern (MID)
AF:
0.639
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
0.544
AC:
36951
AN:
67970
Other (OTH)
AF:
0.668
AC:
1413
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1660
3320
4979
6639
8299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.592
Hom.:
43556
Bravo
AF:
0.683
Asia WGS
AF:
0.781
AC:
2715
AN:
3478
EpiCase
AF:
0.557
EpiControl
AF:
0.565

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 26, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 29, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The SUMF1 c.1116T>C (p.Thr372Thr) variant involves the alteration of a non-conserved nucleotide causes a synonymous change and 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may alter ESE binding. This variant was found in 176669/274930 control chromosomes (58685 homozygotes)(gnomAD) at a frequency of 0.6425963, which is approximately 575 times the estimated maximal expected allele frequency of a pathogenic SUMF1 variant (0.001118). The observed frequency the C allele, 0.64, indicates the variant of interest to be the major allele (allele more commonly observed in the general population). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign. -

Multiple sulfatase deficiency Benign:5
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 22, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.8
DANN
Benign
0.45
PhyloP100
-0.094
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2633852; hg19: chr3-4403837; COSMIC: COSV55991868; API